Symbols / ASBP Stock $0.24 +18.15% Aspire Biopharma Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
ASBP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Kraig T. Higginson
Exch · Country NCM · United States
Market Cap 1.22M
Enterprise Value 5.20M
Income -24.48M
Sales 6.20K
FCF (ttm) 15.39M
Book/sh -1.80
Cash/sh 0.20
Employees —
Insider 10d —
IPO Apr 11, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 196.20
P/B -0.13
P/C —
EV/EBITDA —
EV/Sales 838.65
Quick Ratio 0.13
Current Ratio 0.17
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -16.38
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -4.47%
ROE —
ROIC —
Gross Margin -1.87%
Oper. Margin -434.04%
Profit Margin 0.00%
Shs Outstand 5.02M
Shs Float 4.36M
Insider Own 7.47%
Instit Own 8.57%
Short Float 7.89%
Short Ratio 0.49
Short Interest 373.38K
52W High 35.00
vs 52W High -99.31%
52W Low 0.16
vs 52W Low 47.68%
Beta 1.00
Impl. Vol. —
Rel Volume 34.03
Avg Volume 6.01M
Volume 204.36M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.20
Price $0.24
Change 18.15%
About

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.24
Latest analyst target
3. DCF / Fair value
$55.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.24
Low
—
High
—
Mean
—
News
RSS: Latest ASBP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-06-05 FELL DONALD G. Director — 20,000 $0.39 $7,800
2025-06-05 FELL DONALD G. Director — 20,000 $0.39 $7,800
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.01
0.00
0.00
0.00
Operating Revenue
0.01
0.00
0.00
0.00
Cost Of Revenue
0.01
0.00
0.00
0.00
Reconciled Cost Of Revenue
0.01
0.00
0.00
0.00
Gross Profit
-0.00
0.00
0.00
0.00
Operating Expense
19.35
+1498.12%
1.21
-9.65%
1.34
+124.68%
0.60
Research And Development
0.92
+540.02%
0.14
+100.36%
0.07
-58.90%
0.18
Selling General And Administration
18.43
+1627.80%
1.07
-20.42%
1.34
+218.20%
0.42
Selling And Marketing Expense
0.79
+526.38%
0.13
+218.07%
0.04
-12.84%
0.05
General And Administrative Expense
17.64
+1775.48%
0.94
-29.83%
1.34
+256.72%
0.38
Other Gand A
17.64
+1775.48%
0.94
-29.83%
1.34
+256.72%
0.38
Total Expenses
19.36
+1498.64%
1.21
-9.65%
1.34
+124.68%
0.60
Operating Income
-19.35
-1498.13%
-1.21
+9.65%
-1.34
-124.68%
-0.60
EBITDA
-15.95
-1217.20%
-1.21
-127.07%
4.47
+849.89%
-0.60
Normalized EBITDA
-15.49
-1179.28%
-1.21
-127.07%
4.47
+849.89%
-0.60
Reconciled Depreciation
—
0.00
0.00
0.00
EBIT
-15.95
-1217.20%
-1.21
-127.07%
4.47
+849.89%
-0.60
Total Unusual Items
-0.46
0.00
—
—
Total Unusual Items Excluding Goodwill
-0.46
0.00
—
—
Special Income Charges
-0.36
0.00
—
—
Other Special Charges
0.36
—
—
—
Net Income
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Pretax Income
-24.48
-1770.40%
-1.31
-129.32%
4.46
+848.39%
-0.60
Net Non Operating Interest Income Expense
-8.53
-8606.45%
-0.10
-101.69%
5.80
0.00
Interest Expense Non Operating
8.53
+8606.45%
0.10
+992.88%
0.01
0.00
Net Interest Income
-8.53
-8606.45%
-0.10
-101.69%
5.80
0.00
Interest Expense
8.53
+8606.45%
0.10
+992.88%
0.01
0.00
Interest Income Non Operating
—
0.55
-90.56%
5.81
—
Interest Income
—
0.55
-90.56%
5.81
—
Other Income Expense
3.40
+137.36%
-9.11
—
—
Other Non Operating Income Expenses
3.86
+142.40%
-9.11
—
—
Gain On Sale Of Security
-0.10
—
—
—
Tax Provision
0.00
-100.00%
0.00
+110.60%
0.00
-23.16%
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Net Income From Continuing Operation Net Minority Interest
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Net Income From Continuing And Discontinued Operation
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Net Income Continuous Operations
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Normalized Income
-24.02
-1733.89%
-1.31
-129.34%
4.46
+847.61%
-0.60
Net Income Common Stockholders
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Diluted EPS
—
-1.14
-129.34%
3.88
+847.61%
-0.52
Basic EPS
—
-1.14
-129.34%
3.88
+847.61%
-0.52
Basic Average Shares
—
1.15
+0.00%
1.15
+0.00%
1.15
Diluted Average Shares
—
1.15
+0.00%
1.15
+0.00%
1.15
Diluted NI Availto Com Stockholders
-24.48
-1768.95%
-1.31
-129.34%
4.46
+847.61%
-0.60
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1.31
+786.66%
0.15
+220.50%
0.05
+104.87%
0.02
Current Assets
1.31
+786.66%
0.15
+220.50%
0.05
+104.87%
0.02
Cash Cash Equivalents And Short Term Investments
1.00
+27532.92%
0.00
-67.49%
0.01
+29305.26%
0.00
Cash And Cash Equivalents
1.00
+27532.92%
0.00
-67.49%
0.01
+29305.26%
0.00
Cash Financial
1.00
+27532.92%
0.00
-67.49%
0.01
+29305.26%
0.00
Receivables
—
0.00
0.00
0.00
Inventory
0.25
0.00
—
—
Prepaid Assets
0.06
-61.83%
0.14
+312.45%
0.04
+55.56%
0.02
Total Non Current Assets
0.00
0.00
0.00
0.00
Goodwill And Other Intangible Assets
—
—
4.97
+1.55%
4.90
Total Liabilities Net Minority Interest
7.69
+355.46%
1.69
+216.10%
0.53
+252.90%
0.15
Current Liabilities
7.59
+349.79%
1.69
+216.10%
0.53
+252.90%
0.15
Payables And Accrued Expenses
2.38
+666.11%
0.31
+79.55%
0.17
+40.77%
0.12
Payables
1.37
+341.00%
0.31
+79.55%
0.17
+40.77%
0.12
Accounts Payable
1.01
+226.99%
0.31
+79.55%
0.17
+40.77%
0.12
Current Accrued Expenses
1.01
0.00
—
—
Current Debt And Capital Lease Obligation
5.18
+308.52%
1.27
+251.28%
0.36
+1189.51%
0.03
Current Debt
5.18
+308.52%
1.27
+251.28%
0.36
+1189.51%
0.03
Other Current Borrowings
3.68
+190.18%
1.27
+251.28%
0.36
+1189.51%
0.03
Other Current Liabilities
0.04
-63.11%
0.11
+17635.78%
0.00
+0.00%
0.00
Total Non Current Liabilities Net Minority Interest
0.10
0.00
0.00
-100.00%
0.00
Other Non Current Liabilities
—
—
3.85
0.00%
3.85
Stockholders Equity
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Common Stock Equity
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Capital Stock
0.00
+411.59%
0.00
-99.69%
0.02
-90.07%
0.22
Common Stock
0.00
+411.59%
0.00
-99.69%
0.02
-90.07%
0.22
Preferred Stock
0.00
0.00
0.00
—
Share Issued
4.00
+247.77%
1.15
+0.00%
1.15
+0.00%
1.15
Ordinary Shares Number
4.00
+247.77%
1.15
+0.00%
1.15
+0.00%
1.15
Additional Paid In Capital
20.88
+1587.96%
1.24
+29.20%
0.96
+26.32%
0.76
Retained Earnings
-27.26
-881.48%
-2.78
-89.27%
-1.47
-32.40%
-1.11
Total Equity Gross Minority Interest
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Total Capitalization
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Working Capital
-6.28
-307.81%
-1.54
-215.68%
-0.49
-278.81%
-0.13
Invested Capital
-1.20
-339.54%
-0.27
-114.78%
-0.13
-26.19%
-0.10
Total Debt
5.18
+308.52%
1.27
+251.28%
0.36
+1189.51%
0.03
Net Debt
4.17
+230.22%
1.26
+261.47%
0.35
+1151.25%
0.03
Net Tangible Assets
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Tangible Book Value
-6.38
-314.02%
-1.54
-215.68%
-0.49
-278.80%
-0.13
Current Notes Payable
1.50
0.00
—
—
Derivative Product Liabilities
0.10
0.00
—
—
Dueto Related Parties Current
0.35
0.00
—
—
Preferred Stock Equity
—
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.92
-1756.62%
-0.27
-2481.34%
0.01
+107.79%
-0.14
Cash Flow From Continuing Operating Activities
-4.92
-1756.62%
-0.27
-2481.34%
0.01
+107.79%
-0.14
Net Income From Continuing Operations
-24.48
-1768.95%
-1.31
-264.80%
-0.36
+39.87%
-0.60
Depreciation Amortization Depletion
—
0.00
0.00
0.00
Depreciation And Amortization
—
0.00
0.00
0.00
Other Non Cash Items
8.29
—
—
—
Stock Based Compensation
14.13
0.00
—
—
Operating Gains Losses
-3.40
—
—
—
Gain Loss On Investment Securities
-3.77
—
—
—
Change In Working Capital
0.53
-48.94%
1.04
+182.19%
0.37
-18.49%
0.45
Change In Receivables
—
0.00
0.00
-100.00%
0.40
Change In Inventory
-0.25
0.00
—
—
Change In Prepaid Assets
0.17
+259.35%
-0.11
-774.85%
-0.01
+44.44%
-0.02
Change In Payables And Accrued Expense
0.72
-37.32%
1.15
+2206.33%
0.05
-65.56%
0.15
Change In Accrued Expense
1.05
0.00
-100.00%
0.08
+78.37%
0.04
Change In Payable
-0.32
-128.06%
1.15
+2206.33%
0.05
-51.29%
0.10
Change In Account Payable
-0.32
-230.64%
0.25
+395.32%
0.05
-51.29%
0.10
Change In Other Current Liabilities
-0.11
0.00
-100.00%
0.33
+585.11%
-0.07
Investing Cash Flow
—
0.00
0.00
+100.00%
-4.90
Cash Flow From Continuing Investing Activities
—
—
-0.08
+98.45%
-4.90
Capital Expenditure
—
—
-0.08
+98.45%
-4.90
Net Intangibles Purchase And Sale
—
—
-0.08
+98.45%
-4.90
Financing Cash Flow
5.92
+2199.19%
0.26
0.00
-100.00%
4.85
Cash Flow From Continuing Financing Activities
5.92
+2199.19%
0.26
0.00
-100.00%
4.85
Net Issuance Payments Of Debt
6.57
0.00
—
—
Issuance Of Debt
10.30
0.00
—
—
Repayment Of Debt
-3.73
0.00
—
—
Short Term Debt Issuance
10.30
0.00
—
—
Short Term Debt Payments
-3.73
0.00
—
—
Net Short Term Debt Issuance
6.57
0.00
—
—
Net Common Stock Issuance
0.27
+3.18%
0.26
0.00
-100.00%
1.00
Net Other Financing Charges
-0.91
—
—
3.85
Changes In Cash
1.00
+13364.43%
-0.01
-167.72%
0.01
+106.00%
-0.19
Beginning Cash Position
0.00
-67.49%
0.01
+29305.26%
0.00
-99.98%
0.19
End Cash Position
1.00
+27532.92%
0.00
-67.49%
0.01
+29305.26%
0.00
Free Cash Flow
-4.92
-1756.62%
-0.27
-2481.34%
0.01
+100.22%
-5.04
Interest Paid Supplemental Data
0.04
0.00
0.00
—
Income Tax Paid Supplemental Data
—
0.00
0.00
—
Common Stock Issuance
0.27
+3.18%
0.26
0.00
-100.00%
1.00
Issuance Of Capital Stock
0.27
+3.18%
0.26
0.00
-100.00%
1.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category